# Study Investigating the Safety and Tolerability of Multiple Doses of PF-02545920 in Subjects With Schizophrenia

> **NCT00463372** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 40 (—)

## Conditions studied

- Schizophrenia
- Schizo-affective Disorder

## Interventions

- **DRUG:** PF-02545920

## Key facts

- **NCT ID:** NCT00463372
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** —
- **Final completion:** 2007-05
- **Target enrollment:** 40 (—)
- **Last updated:** 2018-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00463372

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00463372, "Study Investigating the Safety and Tolerability of Multiple Doses of PF-02545920 in Subjects With Schizophrenia". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00463372. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*